Changes in lipid metabolism in pediatric patients with severe sepsis and septic shock

Ana Carolina G Bermudes1, Werther B de Carvalho1, Patricia Zamberlan2

  • 1Pediatric Critical Care Unit, Instituto da Criança da Faculdade de Medicina, São Paulo University, São Paulo, Brazil.

Insights

Critically ill children with severe sepsis/septic shock show altered lipid profiles, with lower cholesterol and lipoproteins. Lipid levels improved as inflammation decreased, indicating a link between inflammation and lipid changes in pediatric intensive care unit patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Clinical Biochemistry
  • Infectious Diseases

Background:

  • Systemic inflammatory response syndrome (SIRS) in critically ill children significantly impacts metabolic processes.
  • Understanding lipid profile alterations in pediatric sepsis is crucial for patient management.
  • Limited data exists on the relationship between inflammatory intensity and lipid changes in pediatric intensive care unit (PICU) patients.

Purpose of the Study:

  • To investigate the relationship between the intensity of the inflammatory response and lipid profile changes in critically ill pediatric patients with severe sepsis/septic shock.
  • To evaluate alterations in total cholesterol, HDL, LDL, triacylglycerols, and apolipoproteins during severe sepsis/septic shock.

Main Methods:

  • A prospective, observational study conducted in a 15-bed PICU.
  • Lipid profiles of 40 pediatric patients with severe sepsis/septic shock were analyzed on days 1 and 7 of hospitalization.
  • C-reactive protein served as the systemic inflammation marker; 42 healthy pediatric patients formed the control group.

Main Results:

  • On day 1, PICU patients exhibited significantly lower total cholesterol, HDL, and LDL, with higher triacylglycerols compared to controls.
  • A significant increase in total cholesterol, HDL, LDL, and apolipoprotein levels was observed from day 1 to day 7.
  • Lower serum lipoproteins and apolipoproteins were negatively correlated with C-reactive protein levels.

Conclusions:

  • Severe sepsis/septic shock in children is associated with reduced serum lipoproteins and apolipoproteins.
  • Improving inflammatory response correlated with increased levels of total cholesterol, HDL, LDL, and apolipoproteins.
  • A direct relationship exists between lipid profile changes and inflammation intensity in critically ill pediatric patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
251
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
316
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
227